Sensus Healthcare, Inc. announced its financial results for the quarter and year ended December 31, 2025, reporting revenues of $4.9 million for the quarter and $27.5 million for the year, with a net loss of $3.2 million for the quarter and $7.7 million for the year. The company highlighted the publication of dedicated CPT codes for its SRT technology, providing reimbursement certainty, and expects sequential-quarter revenue growth in Q1 2026 and full-year profitability.
Key takeaways
Revenues for Q4 2025 were $4.9 million, down from $13.1 million in Q4 2024, primarily due to reduced sales to the largest customer.
Net loss for Q4 2025 was $3.2 million ($0.19 per share), compared to net income of $1.5 million ($0.09 per diluted share) in Q4 2024.
The company shipped 14 SRT systems in Q4 2025, with none to its historically largest customer, up from six systems in Q3 2025 excluding that customer.
The 2026 CMS Physician Fee Schedule Final Rule provides a 300% per-fraction increase to the delivery code for SRT, effective January 1, 2026.
The company ended 2025 with $22.1 million in cash and cash equivalents and no debt.
Management expects shipments in Q1 2026 to exceed Q4 2025 levels without contribution from the historically largest customer and aims for full-year profitability in 2026.